IS7726A - Pyrazólólpyridín og aðferðir til þess að búa þau til og nota - Google Patents

Pyrazólólpyridín og aðferðir til þess að búa þau til og nota

Info

Publication number: IS7726A
Authority: IS; Iceland
Prior art keywords: pyrazolol; pyridine; preparation; methods; pyrazolol pyridine
Prior art date: 2002-09-06

Application number

IS7726A

Other languages

English (en)

Inventor

Lee Wen-Cherng

Lyne Paul

Singh Juswinder

Beth Carter Mary

Chuaqui Claudio

Somerville

Boriack-Sjodin Paula

Sun Lihong

Zheng Zhongli

Original Assignee

Biogen Idec Ma, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-06

Filing date

2005-03-04

Publication date

2005-03-04

2005-03-04 Application filed by Biogen Idec Ma, Inc. filed Critical Biogen Idec Ma, Inc.

2005-03-04 Publication of IS7726A publication Critical patent/IS7726A/is

Links

GGCFMDYFNVQSFR-UHFFFAOYSA-N 1,2-dihydropyrazol-3-one;pyridine Chemical compound C1=CC=[NH+]C=C1.[O-]C=1C=CNN=1 GGCFMDYFNVQSFR-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS7726A 2002-09-06 2005-03-04 Pyrazólólpyridín og aðferðir til þess að búa þau til og nota IS7726A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40881102P	2002-09-06	2002-09-06
PCT/US2003/027722 WO2004022054A1 (en)	2002-09-06	2003-09-05	Pyrazolopyridines and methods of making and using the same

Publications (1)

Publication Number	Publication Date
IS7726A true IS7726A (is)	2005-03-04

Family

ID=31978684

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS7725A IS7725A (is)	2002-09-06	2005-03-04	Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
IS7726A IS7726A (is)	2002-09-06	2005-03-04	Pyrazólólpyridín og aðferðir til þess að búa þau til og nota

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IS7725A IS7725A (is)	2002-09-06	2005-03-04	Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra

Country Status (20)

Country	Link
US (1)	US7691865B2 (is)
EP (1)	EP1551398A4 (is)
JP (1)	JP2006502165A (is)
KR (1)	KR20050057235A (is)
CN (1)	CN1694698A (is)
AR (1)	AR041207A1 (is)
AU (1)	AU2003268447B2 (is)
BR (1)	BR0314053A (is)
CA (1)	CA2497970A1 (is)
EA (1)	EA009441B1 (is)
GE (1)	GEP20074125B (is)
IS (2)	IS7725A (is)
MX (1)	MXPA05002443A (is)
NO (1)	NO20051503D0 (is)
NZ (1)	NZ539069A (is)
PL (1)	PL375699A1 (is)
RS (1)	RS20050200A (is)
UA (1)	UA80295C2 (is)
WO (1)	WO2004022054A1 (is)
ZA (1)	ZA200501856B (is)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
JP4931589B2 (ja) *	2004-07-02	2012-05-16	正明松岡	ＴＧＦβ２を標的としたアルツハイマー病治療薬のスクリーニング法
AU2005295734A1 (en) *	2004-10-15	2006-04-27	Biogen Idec Ma Inc.	Methods of treating vascular injuries
US20070155738A1 (en)	2005-05-20	2007-07-05	Alantos Pharmaceuticals, Inc.	Heterobicyclic metalloprotease inhibitors
US7709468B2 (en)	2005-09-02	2010-05-04	Abbott Laboratories	Imidazo based heterocycles
EP1873157A1 (en) *	2006-06-21	2008-01-02	Bayer Schering Pharma Aktiengesellschaft	Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
PL2918288T3 (pl)	2006-10-03	2018-02-28	Genzyme Corporation	Zastosowanie antagonistów TGF beta do leczenia niemowląt obarczonych ryzykiem rozwinięcia dysplazji oskrzelowo-płucnej
US20090082354A1 (en) *	2007-09-20	2009-03-26	Wyeth	Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof
JP2011513203A (ja) *	2008-03-14	2011-04-28	大塚製薬株式会社	Ｍｍｐ−２及び／又はｍｍｐ−９阻害剤
CN101544634B (zh) *	2008-03-27	2011-08-10	天津药物研究院	2-苯基-3-取代吡唑并[1,5-a]吡啶类衍生物及其制备方法和用途
EP2402344A1 (en) *	2010-06-29	2012-01-04	Basf Se	Pyrazole fused bicyclic compounds
EP2402335A1 (en) *	2010-06-29	2012-01-04	Basf Se	Pyrazolopyridine compounds
US8871744B2 (en)	2010-07-21	2014-10-28	B & G Partyers, LLC	Compounds and methods for selectively targeting tumor-associated mucins
WO2013014262A1 (en)	2011-07-27	2013-01-31	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for diagnosing and treating myhre syndrome
CA2853484C (en)	2011-10-26	2018-08-21	Seattle Children's Research Institute	Cysteamine in the treatment of fibrotic disease
RU2693480C2 (ru)	2013-03-14	2019-07-03	Толеро Фармасьютикалз, Инк.	Ингибиторы jak2 и alk2 и способы их использования
NZ718190A (en)	2013-08-23	2017-10-27	Neupharma Inc	Substituted quinazolines for inhibiting kinase activity
US9969687B2 (en)	2013-12-23	2018-05-15	Norgine B.V.	Compounds useful as CCR9 modulators
WO2015144801A1 (en) *	2014-03-27	2015-10-01	Janssen Pharmaceutica Nv	SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND 2,3-DIHYDRO-1H-IMIDAZO[1,2-b]PYRAZOLE DERIVATIVES AS ROS1 INHIBITORS
AU2017312561B2 (en) *	2016-08-15	2022-06-30	Neupharma, Inc.	Certain chemical entities, compositions, and methods
CA3103995A1 (en)	2018-07-26	2020-01-30	Sumitomo Dainippon Pharma Oncology, Inc.	Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
WO2020201362A2 (en)	2019-04-02	2020-10-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods of predicting and preventing cancer in patients having premalignant lesions
WO2020231990A1 (en) *	2019-05-13	2020-11-19	Relay Therapeutics, Inc.	Fgfr inhibitors and methods of use thereof
US20230090552A1 (en)	2020-01-08	2023-03-23	Synthis Therapeutics, Inc.	Alk5 inhibitor conjugates and uses thereof
CN112707902B (zh) *	2020-03-23	2022-04-15	杭州阿诺生物医药科技有限公司	TGF-β受体抑制剂
CN114380818A (zh) *	2020-10-16	2022-04-22	四川科伦博泰生物医药股份有限公司	吡唑并吡啶类化合物，及其药物组合物、制备方法和用途
CN121712526A (zh)	2023-06-13	2026-03-20	辛瑟斯治疗股份有限公司	抗cd5抗体及其用途

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3940486A (en) *	1971-05-10	1976-02-24	Ciba-Geigy Corporation	Imidazole derivatives in the treatment of pain
US4302464A (en)	1980-10-16	1981-11-24	Pfizer Inc.	Imidazolylpyridine therapeutic agents
US4686231A (en) *	1985-12-12	1987-08-11	Smithkline Beckman Corporation	Inhibition of 5-lipoxygenase products
JP2753659B2 (ja) *	1990-09-03	1998-05-20	株式会社大塚製薬工場	ピラゾール誘導体
IL104369A0 (en)	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
US5656644A (en) *	1994-07-20	1997-08-12	Smithkline Beecham Corporation	Pyridyl imidazoles
US5593991A (en) *	1993-07-16	1997-01-14	Adams; Jerry L.	Imidazole compounds, use and process of making
US5670527A (en)	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
US5559137A (en)	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds
GB9423460D0 (en) *	1994-11-21	1995-01-11	Merck Sharp & Dohme	Therapeutic agents
US5514505A (en) *	1995-05-15	1996-05-07	Xerox Corporation	Method for obtaining improved image contrast in migration imaging members
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
US6369068B1 (en) *	1995-06-07	2002-04-09	Smithkline Beecham Corporation	Amino substituted pyrimidine containing compounds
US5658903A (en) *	1995-06-07	1997-08-19	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
WO1997001575A1 (en)	1995-06-29	1997-01-16	Fujisawa Pharmaceutical Co., Ltd.	Substance wf16616, process for production thereof, and use thereof
US5792778A (en) *	1995-08-10	1998-08-11	Merck & Co., Inc.	2-substituted aryl pyrroles, compositions containing such compounds and methods of use
US5837719A (en)	1995-08-10	1998-11-17	Merck & Co., Inc.	2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
US6083949A (en) *	1995-10-06	2000-07-04	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
US5717100A (en) *	1995-10-06	1998-02-10	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
GB2306108A (en)	1995-10-13	1997-04-30	Merck & Co Inc	Treatment of Raf-mediated cancers with imidazole derivatives
GB9525296D0 (en) *	1995-12-11	1996-02-07	Merck Sharp & Dohme	Therapeutic agents
ZA9610687B (en) *	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
ES2205167T3 (es) *	1996-01-11	2004-05-01	Smithkline Beecham Corporation	Nuevos compuestos de imidazol sustituidos.
ZA97175B (en)	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
EP0885217A4 (en)	1996-02-01	1999-04-21	Smithkline Beecham Corp	ENDOTHELIN RECEPTOR ANTAGONISTS
EP1005343A1 (en)	1996-03-08	2000-06-07	Smithkline Beecham Corporation	Use of csaid?tm compounds as inhibitors of angiogenesis
JP2000506532A (ja) *	1996-03-13	2000-05-30	スミスクライン・ビーチャム・コーポレイション	サイトカイン介在疾患の治療にて有用な新規ピリミジン化合物
JP2000507558A (ja) *	1996-03-25	2000-06-20	スミスクライン・ビーチャム・コーポレイション	Ｃｎｓ損傷についての新規な治療
EP0889887A4 (en) *	1996-03-25	2003-06-11	Smithkline Beecham Corp	TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES
US5883105A (en) *	1996-04-03	1999-03-16	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US5872136A (en) *	1996-04-03	1999-02-16	Merck & Co., Inc.	Arylheteroaryl inhibitors of farnesyl-protein transferase
US5854265A (en)	1996-04-03	1998-12-29	Merck & Co., Inc.	Biheteroaryl inhibitors of farnesyl-protein transferase
US6080870A (en) *	1996-04-03	2000-06-27	Merck & Co., Inc.	Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US5880140A (en) *	1996-04-03	1999-03-09	Merck & Co., Inc.	Biheteroaryl inhibitors of farnesyl-protein transferase
US5939557A (en)	1996-04-03	1999-08-17	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
EP0906307B1 (en) *	1996-06-10	2005-04-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
US5854264A (en)	1996-07-24	1998-12-29	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
ES2215242T3 (es) *	1996-11-19	2004-10-01	Amgen Inc.	Agentes antiinflamatorios de pirrol condensado sustituido con arilo y heteroarilo.
US6096753A (en) *	1996-12-05	2000-08-01	Amgen Inc.	Substituted pyrimidinone and pyridone compounds and methods of use
US6410729B1 (en) *	1996-12-05	2002-06-25	Amgen Inc.	Substituted pyrimidine compounds and methods of use
US5939439A (en) *	1996-12-30	1999-08-17	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
IL132318A0 (en)	1997-04-24	2001-03-19	Ortho Mcneil Pharm Inc	Substituted imidazoles useful in the treatment of inflammatory diseases
US6514977B1 (en) *	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
US6087496A (en) *	1998-05-22	2000-07-11	G. D. Searle & Co.	Substituted pyrazoles suitable as p38 kinase inhibitors
PL336990A1 (en) *	1997-05-22	2000-07-31	Searle & Co	3(5)-heteroaryl group substituted pyrazoles as inhibitors of kinase p 38
AU7726898A (en) *	1997-05-22	1998-12-11	G.D. Searle & Co.	Pyrazole derivatives as p38 kinase inhibitors
PT988301E (pt) *	1997-06-12	2006-10-31	Aventis Pharma Ltd	Acetais ciclicos de imidazolilo
EP1023066A4 (en)	1997-06-13	2001-05-23	Smithkline Beecham Corp	NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND
WO1999003837A1 (en) *	1997-06-30	1999-01-28	Ortho-Mcneil Pharmaceutical, Inc.	2-substituted imidazoles useful in the treatment of inflammatory diseases
GB9713726D0 (en)	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds
TW517055B (en) *	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
US7301021B2 (en) *	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6562832B1 (en) *	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
AU1924699A (en)	1997-12-19	1999-07-12	Smithkline Beecham Corporation	Compounds of heteroaryl substituted imidazole, their pharmaceutical compositionsand uses
US6599910B1 (en) *	1998-08-20	2003-07-29	Smithkline Beecham Corporation	Substituted triazole compounds
ATE258055T1 (de) *	1998-11-04	2004-02-15	Smithkline Beecham Corp	Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
US6239279B1 (en) *	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
US6288089B1 (en)	1998-12-21	2001-09-11	Michael Zawada	Use of kinase inhibitors for treating neurodegenerative diseases
WO2000039116A1 (en) *	1998-12-25	2000-07-06	Teikoku Hormone Mfg. Co., Ltd.	Aminopyrazole derivatives
AU4327600A (en) *	1999-04-02	2000-10-23	Du Pont Pharmaceuticals Company	Aryl sulfonyls as factor xa inhibitors
DE60001229T2 (de)	1999-04-09	2003-10-30	Smithkline Beecham Corp., Philadelphia	Triarylimidazole
CO5170501A1 (es) *	1999-04-14	2002-06-27	Novartis Ag	AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO
CN1281604C (zh) *	1999-06-03	2006-10-25	帝国脏器制药株式会社	取代吡唑化合物
JP2003503456A (ja) *	1999-07-02	2003-01-28	スチュアートエイ．リプトン	神経傷害またはアポトーシスを軽減する方法
GB9919778D0 (en) *	1999-08-21	1999-10-27	Zeneca Ltd	Chemical compounds
US20030109428A1 (en) *	1999-12-01	2003-06-12	John Bertin	Novel molecules of the card-related protein family and uses thereof
AU2728201A (en)	1999-12-21	2001-07-03	Sugen, Inc.	4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
CO5271680A1 (es)	2000-02-21	2003-04-30	Smithkline Beecham Corp	Compuestos
JP2003525936A (ja)	2000-03-06	2003-09-02	スミスクラインビーチャムパブリックリミテッドカンパニー	Ｒａｆキナーゼ阻害物質としてのイミダゾール誘導体
GB0007405D0 (en)	2000-03-27	2000-05-17	Smithkline Beecham Corp	Compounds
JP4722318B2 (ja) *	2000-06-05	2011-07-13	ローム株式会社	チップ抵抗器
GB0011092D0 (en)	2000-05-08	2000-06-28	Black James Foundation	Gastrin and cholecystokinin receptor ligands (III)
WO2001091749A1 (en) *	2000-06-01	2001-12-06	Merck & Co., Inc.	Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors
AU2001268711A1 (en)	2000-06-23	2002-01-08	Bristol-Myers Squibb Pharma Company	Heteroaryl-phenyl substituted factor xa inhibitors
PE20020506A1 (es) *	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0021726D0 (en) *	2000-09-05	2000-10-18	Astrazeneca Ab	Chemical compounds
DK1318997T3 (da)	2000-09-15	2006-09-25	Vertex Pharma	Pyrazolforbindelser der er nyttige som proteinkinase-inhibitorer
EP1318992B1 (en) *	2000-09-21	2005-07-27	Smithkline Beecham Plc	Imidazole derivatives as raf kinase inhibitors
CA2426337A1 (en)	2000-10-18	2002-04-25	Ortho-Mcneil Pharmaceutical, Inc.	Substituted imidazoles useful in the treatment of inflammatory diseases
US6630325B1 (en)	2000-10-19	2003-10-07	Maine Medical Center Research Institute	Compositions, methods and kits relating to remodel
US6603005B2 (en)	2000-11-15	2003-08-05	Aventis Pharma S.A.	Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
WO2002040468A1 (en) *	2000-11-16	2002-05-23	Smithkline Beecham Corporation	Compounds
GB0027987D0 (en)	2000-11-16	2001-01-03	Smithkline Beecham Plc	Compounds
US20040053943A1 (en) *	2000-11-20	2004-03-18	Adams Jerry L.	Novel compounds
HUP0303653A3 (en) *	2000-12-28	2006-05-29	Ono Pharmaceutical Co	Tricyclic and heterocyclic derivative and pharmaceutical compositions containing them as the active ingredient
GB0102672D0 (en) *	2001-02-02	2001-03-21	Glaxo Group Ltd	Compounds
GB0102668D0 (en) *	2001-02-02	2001-03-21	Glaxo Group Ltd	Compounds
WO2002062787A1 (en) *	2001-02-02	2002-08-15	Glaxo Group Limited	Pyrazoles as tgf inhibitors
GB0102665D0 (en) *	2001-02-02	2001-03-21	Glaxo Group Ltd	Compounds
JP2004521915A (ja) *	2001-02-02	2004-07-22	グラクソ　グループ　リミテッド	Ｔｇｆ過剰発現に対するピラゾール誘導体
CA2445568A1 (en)	2001-04-27	2002-11-07	Vertex Pharmaceuticals Incorporated	Triazole-derived kinase inhibitors and uses thereof
US6787555B2 (en) *	2001-04-30	2004-09-07	The Procter & Gamble Company	Triazole compounds useful in treating diseases associated with unwanted cytokine activity
US6727364B2 (en) *	2001-04-30	2004-04-27	The Procter & Gamble Company	Triazole compounds useful in treating diseases associated with unwanted cytokine activity
IL159811A0 (en)	2001-07-13	2004-06-20	Neurogen Corp	Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
GB0127433D0 (en)	2001-11-15	2002-01-09	Smithkline Beecham Corp	Compounds
US7199120B2 (en) *	2001-12-11	2007-04-03	Smithkline Beecham Corporation	Pyrazolo-pyridine derivatives as antiherpes agents
EP1511738A4 (en) *	2002-05-17	2007-05-09	Scios Inc	TREATMENT OF FIBROPROLIFERATIVE DISEASES USING TGF BETA INHIBITORS
EP1543001B1 (en) *	2002-09-17	2007-08-15	Eli Lilly And Company	Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer
HRP20050252A2 (en) *	2002-09-18	2005-10-31	Pfizer Products Inc.	Novel imidazole compounds as transforming growth factor (tfg) inhibitors
WO2004026863A1 (en) *	2002-09-18	2004-04-01	Pfizer Products Inc.	Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
EP1581222A2 (en)	2003-01-02	2005-10-05	Millennium Pharmaceuticals, Inc.	COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
PA8595001A1 (es)	2003-03-04	2004-09-28	Pfizer Prod Inc	Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
MXPA06002567A (es)	2003-09-06	2006-09-04	Vertex Pharma	Moduladores de transportadores con casete de union de atp.

2003
- 2003-05-09 UA UAA200503095A patent/UA80295C2/uk unknown
- 2003-09-05 PL PL03375699A patent/PL375699A1/xx not_active Application Discontinuation
- 2003-09-05 JP JP2004534571A patent/JP2006502165A/ja active Pending
- 2003-09-05 AU AU2003268447A patent/AU2003268447B2/en not_active Ceased
- 2003-09-05 KR KR1020057003874A patent/KR20050057235A/ko not_active Withdrawn
- 2003-09-05 NZ NZ539069A patent/NZ539069A/en unknown
- 2003-09-05 US US10/526,839 patent/US7691865B2/en not_active Expired - Fee Related
- 2003-09-05 CA CA002497970A patent/CA2497970A1/en not_active Abandoned
- 2003-09-05 WO PCT/US2003/027722 patent/WO2004022054A1/en not_active Ceased
- 2003-09-05 BR BR0314053-9A patent/BR0314053A/pt not_active IP Right Cessation
- 2003-09-05 GE GEAP20038727A patent/GEP20074125B/en unknown
- 2003-09-05 EA EA200500450A patent/EA009441B1/ru not_active IP Right Cessation
- 2003-09-05 RS YUP-2005/0200A patent/RS20050200A/sr unknown
- 2003-09-05 EP EP03749412A patent/EP1551398A4/en not_active Withdrawn
- 2003-09-05 CN CNA038248670A patent/CN1694698A/zh active Pending
- 2003-09-05 MX MXPA05002443A patent/MXPA05002443A/es active IP Right Grant
- 2003-09-08 AR ARP030103250A patent/AR041207A1/es unknown
2005
- 2005-03-03 ZA ZA200501856A patent/ZA200501856B/en unknown
- 2005-03-04 IS IS7725A patent/IS7725A/is unknown
- 2005-03-04 IS IS7726A patent/IS7726A/is unknown
- 2005-03-21 NO NO20051503A patent/NO20051503D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1551398A1 (en)	2005-07-13
NZ539069A (en)	2007-03-30
US20060106033A1 (en)	2006-05-18
EA200500450A1 (ru)	2005-08-25
CN1694698A (zh)	2005-11-09
IS7725A (is)	2005-03-04
GEP20074125B (en)	2007-06-11
AR041207A1 (es)	2005-05-11
RS20050200A (sr)	2007-08-03
BR0314053A (pt)	2005-07-19
CA2497970A1 (en)	2004-03-18
WO2004022054A1 (en)	2004-03-18
NO20051503L (no)	2005-03-21
US7691865B2 (en)	2010-04-06
AU2003268447A1 (en)	2004-03-29
KR20050057235A (ko)	2005-06-16
UA80295C2 (en)	2007-09-10
EP1551398A4 (en)	2006-06-07
MXPA05002443A (es)	2005-09-30
EA009441B1 (ru)	2007-12-28
ZA200501856B (en)	2006-04-26
NO20051503D0 (no)	2005-03-21
AU2003268447B2 (en)	2008-07-24
PL375699A1 (en)	2005-12-12
JP2006502165A (ja)	2006-01-19

Publication	Publication Date	Title
IS7726A (is)	2005-03-04	Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
DK1465615T3 (da)	2012-11-12	Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
NO20040640L (no)	2004-08-16	Anordning og fremgangsmate
NO20032220D0 (no)	2003-05-15	Löfteverktöy II og fremgangsmåte for anvendelse av samme
IS8204A (is)	2006-07-01	Tæki og aðferð til að hluta niður
DK1997809T3 (da)	2014-07-21	P38-inhibitorer og fremgangsmåder til anvendelse deraf
IS2675B (is)	2010-09-15	P38-hindrar og aðferðir til notkunar þeirra
IS8146A (is)	2005-11-24	Setnar 3-alkýl og 3-alkenýl asetidín afleiður
IS7701A (is)	2005-02-18	Arípíprazól samsett lyfjaform og aðferð
NO20053817D0 (no)	2005-08-12	Preparater og fremgangsmater for antiviral kombinasjonsterapi.
NO20031776L (no)	2003-10-20	Null-boringskomplettering og produksjonssystem
IS3007B (is)	2018-12-15	Ónæmisbælandi efnasambönd og efnablöndur
DK1715893T3 (da)	2009-11-09	Direkte kompressionsformulering og fremgangsmåde
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
DK1601744T3 (da)	2012-08-20	Forgasningsapparat og fremgangsmåde
NO20053593D0 (no)	2005-07-22	Arylalkylkarbamat-derivater, fremgangsmate og anvendelse derav i terapi
DK1426784T3 (da)	2021-04-12	Indretning og fremgangsmåde til positionsbestemmelse
NO20055778D0 (no)	2005-12-06	Folgesystem og assosiert fremgangsmate
DK1359458T3 (da)	2006-03-20	Brillestel og hængselsenhed til anvendelse deri
NO20044012D0 (no)	2004-09-23	Fremgangsmate og et system
IS7572A (is)	2006-05-30	Aðferð og efni til lækninga
DK1667693T3 (da)	2015-08-31	Præparater og fremgangsmåder til anvendelse af lamellare bodies til terapeutiske formål
NO20044848D0 (no)	2004-11-08	Anordning og fremgangsmate
DK1662867T3 (da)	2014-07-21	Insekticid-forbindelser og fremgangsmåder til valg deraf
IS8489A (is)	2006-05-26	Umritunarstillar og aðferðir þeirra